Migraine Report Migraine-Report | Page 50

Project Progress Report
Table - 17: Changes in VAS and MIDAS after receiving Conventional Treatment
VAS
No. of headache days in
last 90 days
MIDAS
S. No. CRF
No. 1 002 47 F 10 LTF 40 LTF 90 LTF
2 007 39 F 9 5 37 25 90 30
3 012 46 F 6 4 40 25 45 15
4 013 40 F 5 4 16 11 30 15
5 014 27 M 8 5 55 26 90 40
6 017 35 F 9 6 42 21 60 30
7 018 33 F 8 3 25 17 50 25
8 019 38 F 9 4 32 25 45 12
9 020 42 F 8 4 24 18 60 15
10 021 35 F 8 3 28 26 60 15
11 022 40 F 7 3 30 20 30 12
12 023 45 F 8 4 25 17 45 15
13 025 52 F 9 4 25 15 90 30
14 026 35 F 9 4 34 20 60 18
15 027 54 F 8 3 32 15 75 35
16 028 21 M 9 4 40 12 60 20
17 030 33 F 8 4 38 16 75 25
18 032 32 F 9 3 43 17 45 15
19 033 28 M 9 3 37 31 90 38
20 034 20 M 8 4 32 10 30 10
21 035 43 M 9 3 25 11 60 25
22 037 38 M 9 3 39 19 36 18
23 038 30 F 8 4 25 9 40 16
24 040 31 F 7 3 35 8 45 20
25 041 33 M 8 3 50 7 60 25
26 042 45 F 9 5 40 7 50 25
27 043 48 F 8 4 40 10 30 15
Age Sex
Pre-
Post-
Pre-
Post-
Pre-
Post-
Treatment Treatment Treatment Treatment Treatment Treatment
Randomized controlled clinical trial to evaluate prophylactic
50 properties of Ayu rv ed ic Treatment Protocol in
refractory and chronic migraine patients